Regulatory medical writing plays a crucial role in the pharmaceutical and biotechnology industries. It ensures that critical clinical and non-clinical data are appropriately documented and communicated to regulatory authorities, facilitating the approval and monitoring of new drugs and medical products. This blog will provide a comprehensive overview of regulatory medical writing, its importance, key documents, and industry best practices.
Regulatory medical writing involves the preparation of scientific documents required by regulatory agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other global health authorities. These documents must adhere to applicable guidelines and accurately present clinical trial results, drug safety data, and other critical information.
Regulatory writers produce a wide variety of clinical documents throughout the life cycle of a (potential) treatment, starting with describing and reporting data from clinical trials, through to preparing regulatory submission documents. If the treatment is approved by a regulatory authority, regulatory writers also produce post approval reports on the use of the treatment in patients. Examples of clinical documents produced by regulatory writers most commonly include Investigator Brochures (IBs), Clinical Study Protocols, Clinical Study Reports (CSRs), and the Common Technical Document (CTD). The audience for these documents are often regulatory authorities and ethics committees. The key national regulatory authorities are:
Regulatory writing acts as the backbone of drug development, ensuring that every piece of data is communicated accurately to meet compliance standards and ultimately protect patients – including the following:
In the ever-changing regulatory environment, experienced regulatory writers can add a lot of value to the production of clinical study documentation. As an integral part of the clinical research process, regulatory writers can act as a pool of knowledge at every step, from protocol development to the drug submission process. Some regulatory writers become experts in a particular therapeutic area or disease and can provide invaluable insights to the sponsors and/or study teams. Regulatory writers can also perform quality control (QC), peer review and provide other editorial support on documents produced by sponsors and/or study teams, if required.
There are several key guidelines and strategies to keep in mind for producing accurate, concise, and inspection-ready regulatory documents. These include:
Regulatory medical writing is a specialised discipline that plays a pivotal role in drug development and regulatory submissions. It requires a combination of scientific expertise, writing proficiency, and adherence to regulatory requirements. As the pharmaceutical and biotech industries continue to evolve, skilled regulatory medical writers will remain in high demand, ensuring that critical medical documents are prepared with accuracy and compliance.
Quanticate offers a wide range of medical writing services including regulatory writing, publication writing, transparency writing and safety writing in support of any or all stages of the pharmaceutical development life cycle. Our medical writers deliver accurate, timely and cost-effective documents to the highest of ethical and scientific standards. Our team is trusted by top pharma and flexible in our ability to adapt to client systems and standard operating procedures (SOPs). Please submit a request for information (RFI) if you would like to speak to a member of our team who can support your trial.